- The 9th PharmaMed 2026 in New Delhi brings together policymakers, regulators, and industry leaders to discuss India’s shift toward an innovation-driven, equitable, and globally competitive healthcare ecosystem aligned with the Viksit Bharat 2047 vision.
- The conference highlights regulatory harmonisation, quality assurance, innovation, and last-mile access.
- The one-day conference will convene key stakeholders from across the pharmaceutical ecosystem for a high-level dialogue on the future of India’s pharma sector.
- The discussions will focus on critical priorities such as strengthening quality assurance, advancing regulatory harmonisation, fostering innovation, and ensuring equitable access to affordable medicines.
- Theme: ‘Healthcare Equity: Reaching Every Citizen of Viksit Bharat’.
PharmaMed 2026 will feature a series of high-level sessions addressing key themes, including the following:
- Redefining India’s Pharmaceutical Leadership: From Volume to Value, with a focus on innovation, R&D, biologics, and advanced therapies.
- Strengthening Pharmaceutical Quality: Regulatory Harmonization & Global Compliance, covering GMP standards, regulatory alignment, and global best practices.
- Recent regulatory developments, including a presentation by CDSCO on Post-Approval Changes (PAC) and compliance pathways.
- Supply Chain Challenges & Tackling Counterfeit Drugs, focusing on API dependency, logistics efficiency, and domestic manufacturing resilience.
- Last-Mile Access to Medicines, highlighting digital health, e-pharmacy frameworks, and improving affordability and accessibility.
The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers is supporting the country’s pharmaceutical and medtech sector to drive innovation and Atma Nirbharta, with focused policy interventions, infrastructure development & industry-academia partnerships, aligned with the broader vision of Viksit Bharat 2047.
Source: .PIB